alanine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baglioni, C; Bussolino, F; Camussi, G; Herrick-Davis, K; Tetta, C | 1 |
| Camacho, PL; Geiger, E; Thompson, DH; Vigh, G; Webster, R | 1 |
| Fischereder, M; Nath, KA; Trick, W | 1 |
| Carlson, SA; Chatterjee, TK; Fisher, RA | 1 |
| Ishii, I; Izumi, T; Shimizu, T; Tsukamoto, H; Ui, M; Umeyama, H | 1 |
| Ichikawa, H; Kokura, S; Kondo, M; Naito, Y; Takahashi, S; Takano, H; Tomii, T; Yoshida, N; Yoshikawa, T | 1 |
1 review(s) available for alanine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Therapeutic strategies in the prevention of acute renal failure.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Alanine; Animals; Atrial Natriuretic Factor; Calcium Channel Blockers; Endothelins; Free Radical Scavengers; Glycine; Humans; Misoprostol; Nitric Oxide; Platelet Activating Factor | 1994 |
5 other study(ies) available for alanine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
Topics: Alanine; Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cells, Cultured; Enzyme Activation; Humans; Methionine; Molecular Sequence Data; Neutrophils; Norleucine; Oligopeptides; Peptide Fragments; Phagocytosis; Platelet Activating Factor; Rats; Uteroglobin | 1991 |
Separation of the enantiomeric intermediates of some platelet-activating factor analogues on a naphthylalanine-type Pirkle column.
Topics: Alanine; Chromatography; Platelet Activating Factor; Stereoisomerism | 1990 |
Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230.
Topics: Alanine; Amino Acid Sequence; Animals; Conserved Sequence; Dose-Response Relationship, Drug; Enzyme Activation; Glutamic Acid; GTP-Binding Proteins; Inositol Phosphates; Mutagenesis, Site-Directed; Mutation; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoinositide Phospholipase C; Phosphoric Diester Hydrolases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Signal Transduction | 1996 |
Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants.
Topics: Alanine; Amino Acid Sequence; Amino Acids; Animals; CHO Cells; COS Cells; Cricetinae; Membrane Proteins; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Binding; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Sequence Homology, Amino Acid; Signal Transduction; Zinc | 1997 |
Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Lipid Peroxides; Male; Peroxidase; Platelet Activating Factor; Quinolones; Rats; Rats, Wistar | 1997 |